Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab for skin fibrosis in systemic sclerosis
jRCTs031180370Completed
- Start
- Nov 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of tocilizumab in systemic sclerosis (SSc). Primary endpoint: modified Rodnan total skin score. Started Nov 2013; status: completed.
02
Drugs
tocilizumab
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on jRCTs031180370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180370.